Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-10-17
2006-10-17
O'Sullivan, Peter (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S342000
Reexamination Certificate
active
07122549
ABSTRACT:
In recognition of the need to develop novel therapeutic agents and efficient methods for the synthesis thereof, the present invention provides novel compounds of general formula (I), and methods for the synthesis thereof.In another aspect, the present invention provides pharmaceutical compositions comprising a compound of formula (I) and a pharmaceutically acceptable carrier. In yet another aspect, the present invention provides methods for treating cancer comprising administering a therapeutically effective amount of a compound of formula (I) to a subject in need thereof.
REFERENCES:
patent: 4248863 (1981-02-01), Arai
patent: 4372947 (1983-02-01), Arai et al.
patent: 4419732 (1983-12-01), Lambregts et al.
patent: 4458066 (1984-07-01), Caruthers et al.
patent: 4500707 (1985-02-01), Caruthers et al.
patent: 4668777 (1987-05-01), Caruthers et al.
patent: 4837149 (1989-06-01), Arai et al.
patent: 4973679 (1990-11-01), Caruthers et al.
patent: 5023184 (1991-06-01), Reichenbach et al.
patent: 5153319 (1992-10-01), Caruthers et al.
patent: 5278302 (1994-01-01), Caruthers et al.
patent: 5476925 (1995-12-01), Letsinger et al.
patent: 5539082 (1996-07-01), Nielsen et al.
patent: 5580969 (1996-12-01), Hoke et al.
patent: 5646260 (1997-07-01), Letsinger et al.
patent: 5652355 (1997-07-01), Metelev et al.
patent: 5721362 (1998-02-01), Corey et al.
patent: 5773571 (1998-06-01), Nielsen et al.
patent: 5786461 (1998-07-01), Buchardt et al.
patent: 5834228 (1998-11-01), Becker et al.
patent: 5939273 (1999-08-01), Lussow et al.
patent: 6124292 (2000-09-01), Corey
patent: 6124293 (2000-09-01), Rinchart et al.
patent: 6258539 (2001-07-01), Hunkapiller et al.
patent: 6316214 (2001-11-01), Rinchart et al.
patent: 6348467 (2002-02-01), Corey
patent: 6569859 (2003-05-01), Corey
patent: 6686470 (2004-02-01), Danishefsky et al.
patent: 2003/0083495 (2003-05-01), Corey
patent: 28 39 668 (1979-03-01), None
patent: 0 173 649 (1985-08-01), None
patent: 0 233841 (1987-12-01), None
patent: 0 329 606 (1989-02-01), None
patent: 56-135486 (1981-10-01), None
patent: 57-50896 (1982-03-01), None
patent: 61-58593 (1986-03-01), None
patent: 63-2991 (1988-01-01), None
patent: WO 98/12198 (1998-03-01), None
patent: WO 00/18233 (2000-04-01), None
patent: WO 00/69862 (2000-11-01), None
patent: WO 01/19824 (2001-03-01), None
patent: WO 01/53299 (2001-07-01), None
patent: WO 01/87894 (2001-11-01), None
patent: WO 01/87895 (2001-11-01), None
Zhou et al., Chemical Abstracts, vol. 133:30850, 2000.
Saito et al., Chemical Abstracts, vol. 115:208305, 1991.
Kobo et al., Chemical Abstracts, vol. 108:55713, 1988.
Frincke et al., Chemical Abstracts, vol. 96:31904, 1982.
Arai, et al., “Increased Production of Saframycin A and Isolation of Saframycin S”,The Journal of Antibiotics, XXXIII(9): 951-960, 1980.
Arai, Directed Biosynthesis of New Saframycin Derivatives with Resting Cells of Streptomyces Lavendulae,Antimicrobial Agents and Chemotherapy, 28(1): 5-11, 1985.
Arai, T., “Isoquinolinequinones from Actinomycetes and Sponges”, The Alkaloids, XXI: 56-100, 1983.
Arai, et al., “The Structure of a Novel Antitumor Antibiotic, Saframycin A”,Experientia, 36: 1025-1027, 1980.
Arai, et al., “Some Chemotherapeutic Properties of Two New Antitumor Antibiotics, Saframycins A and C”,Gann, 71: 790-796, 1980.
Arai, et al., In Advances in Cancer Chemotherapy; University Park Press, Baltimore, 235-251, 1978.
Arai, et al., “New Antibiotics Saframycins A, B, C, D and E”,The Journal of Antibiotics, 30: 1015-1018, 1977.
Bodian, et al., “Inhibition of the Fusion-Inducing Conformational Change of Influenza Hemagglutinin by Benzoquinones and Hydroquinones”,Biochemistry, 32: 2967-2978, 1993.
Davidson, B., “Renieramycin G, A New Alkaloid from the Sponge Xestospongia Caycedoi”,Tetrahedron Letters, 33(26): 3721-3724, 1992.
Eisen, et al., “Binding of the Influenza A Virus to Cell-Surface Receptors: Structures of Five Hemagglutinin-Sialyloligosaccharide Complexes Determined by X-Ray Crystallography”,Virology, 232:19-31, 1997.
Ekambareswara, et al., “DNA Sequence Selectivities in the Covalent Bonding of Antibiotic Saframycins Mx1, Mx3, A, and S Deduced from MPE-Fe(II) Footprinting and Exonuclease III Stop Assays”,Biochemistry, 31: 12076-12082, 1992.
Ekambareswara, et al., “Mode of Action of Saframycin Antitumor Antibiotics: Sequence Selectivities in the Covalent Binding of Saframycins A and S to Deoxyribonucleic Acid”,Chem. Res. Toxicol.3:262-267, 1990.
Evans, et al., “Stereoselective of Synthesis of (±)-Cyanocycline”,J. Am. Chem. Soc.108: 2478-2479, 1986.
Flanagan, et al., “Synthetic Studies on Quinocarcin: Total Synthesis of (±)-Quinocarcinamide Via Dipole Cycloaddition of an Azomethine Ylide Generated by NBS Oxidation”,J. Org. Chem.60: 6791-6797, 1995.
Fukuyama, et al., “Total Synthesis of (±)-Saframycin A”,J. Am. Chem. Soc.112: 3712-3713, 1990.
Fukuyama, et al., “Stereocontrolled Total Sunthesis of (±)-Saframycin B”,J. Am. Chem. Soc., 104: 4957-4958, 1982.
Fukuyama, et al., A Stereocontrolled Total Synthesis of (±)-Renieramycin A,Tetrahedron Letters, 31(42): 5989-5992, 1990.
Ha, et al., X-Ray Structures of H5 Avian and H9 Swine Influenza Virus Hemagglutinins Bound to Avian and Human Receptor Analogs,PNAS, 98(20): 11181-11186, 2001.
Hill, et al., “Computer Simulation of the Binding of Saframycin A to d(GATGCATC)”,J. Med. Chem.34: 1990-1998, 1991.
Hoffman, et al., “Structure-Based Identification of an Inducer of the Low-pH Conformational Change in the Influenza Virus Hemagglutinin: Irreversible Inhibition of Infectivity”,Journal of Virology, 71(11): 8808-8820, 1997.
Ishiguro, et al., “Binding of Saframycin A, a Heterocyclic Quinone Anti-Tumor Antibiotic to DNA as Revealed by the Use of the Antibiotic Labeled with [14C]Tyrosine or [14C]Cyanide”,The Journal of Biological Chemistry, 256(5): 2162-2167, 1981.
Ishiguro, et al., “Mode of Action of Saframycin A, A Novel Heterocyclic Quinone Antibiotic. Inhibition of RNA Synthesis in Vivo and In Vitro”,Biochemistry, 17(13): 2545-2550, 1978.
Jimeno, et al., Progress in the Acquisition of New Marine-Derived Anticancer Compounds: Development of Ecteinascidin-743 (ET-743),Drugs Future, 21: 1155-1165, 1996.
Kaneda, et al., “Antitumor Activity of New Semisynthetic Saframycin Derivatives”,Jpn. J. Cancer Res.(Gann), 77: 1043-1049, 1986.
Kaneda, et al., “Biological Activities of Newly Prepared Saframycins”,The Journal of Antibiotics, XL(11): 1640-1643, 1987.
Kishi, et al., “Structure-Activity Relationships of Saframycins”,The Journal of Antibiotics, XXXVII(8): 847-852, 1984.
Kubu, et al., “A Synthesis of the Derivatives of 1,2,3,5,10,10a-Hexahydrobenz[ƒ]Indolizine-6,9-Dione Having Antifungal Activity as a Simple Model of Saframycin A”,Heterocycles, 42(1): 195-211, 1996.
Kubo, et al., “Stereoselective Total Synthesis of (±)-Saframycin B”,J. Org. Chem.53: 4295-4310, 1988.
Kubo, et al., “Synthesis of Saframycins. I. Total Synthesis of (±)—Saframycin B and its Congeners”,Chem. Pharm. Bull.35(5): 2158-2161, 1987.
Kurihara, et al., “Studies Directed Towards Total Synthesis of Saframycin: I. A Synthesis of Hexahydro-1,5-Imino-3-Benzazocin-7,10-Dione”,Tetrahedron Letters, 23(35): 3639-3640, 1982.
Lown, et al., “Molecular Mechanisms of Binding and Single-Strand Scission of Deoxyribonucleic Acid by the Antitumor Antibiotics Saframycins A and C”,Biochemistry, 21(3): 419-428, 1982.
Luo, et al., “Molecular Mechanism Underlying the Action of a Novel Fusion Inhibitor of Influenza A Virus”,Journal of Virology, 71(5): 4062-4070, 1997.
Martinez, et al., “Enantioselective Synthesis of Saframycin A and Evaluation of Antitumor Activity Relative to Ecteinascidin/Saframycin Hybrids”,Organic Letters, 1(1): 75-77, 1999.
Myers Andrew G.
Plowright Alleyn T.
Baker C. Hunter
Choate Hall & Stewart LLP
Jarrell Brenda H.
O'Sullivan Peter
President and Fellows of Harvard College
LandOfFree
Saframycins, analogues and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Saframycins, analogues and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Saframycins, analogues and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3713630